Home  »  Markets   »  Here is a breakdown of major shareholders in InMed...

Here is a breakdown of major shareholders in InMed Pharmaceuticals Inc. (NASDAQ: INM)

InMed Pharmaceuticals Inc. (NASDAQ: INM) is -91.82% lower on its value in year-to-date trading and has touched a low of $2.40 and a high of $54.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INM stock was last observed hovering at around $2.72 in the last trading session, with the day’s loss setting it -0.04% off its average median price target of $20.00 for the next 12 months. It is also 86.6% off the consensus price target high of $20.00 offered by 1 analysts, but current levels are 86.6% higher than the price target low of $20.00 for the same period.

Currently trading at $2.68, the stock is -9.86% and -46.80% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.26 million and changing -1.47% at the moment leaves the stock -80.87% off its SMA200. INM registered -93.94% loss for a year compared to 6-month loss of -85.89%.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The stock witnessed a -18.54% gain in the last 1 month and extending the period to 3 months gives it a -57.14%, and is -29.29% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.59% over the week and 17.73% over the month.

InMed Pharmaceuticals Inc. (INM) has around 13 employees, a market worth around $3.48M and $1.40M in sales. Distance from 52-week low is 11.67% and -95.08% from its 52-week high. The company has generated returns on investments over the last 12 months (-189.70%).

InMed Pharmaceuticals Inc. (INM) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for InMed Pharmaceuticals Inc. (INM) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

InMed Pharmaceuticals Inc. is expected to release its quarterly report on 02/14/2023.The EPS is expected to grow by 12.60% this year

InMed Pharmaceuticals Inc. (INM) Top Institutional Holders

The shares outstanding are 0.94M, and float is at 0.93M with Short Float at 1.47%.

InMed Pharmaceuticals Inc. (INM) Insider Activity

The most recent transaction is an insider purchase by ADAMS ERIC A, the company’s President & CEO. SEC filings show that ADAMS ERIC A bought 14,160 shares of the company’s common stock on Apr 14 at a price of $0.89 per share for a total of $12659.0. Following the purchase, the insider now owns 59003.0 shares.

InMed Pharmaceuticals Inc. disclosed in a document filed with the SEC on Apr 13 that ADAMS ERIC A (President & CEO) bought a total of 8,560 shares of the company’s common stock. The trade occurred on Apr 13 and was made at $0.85 per share for $7276.0. Following the transaction, the insider now directly holds 44843.0 shares of the INM stock.

Still, SEC filings show that on Jan 24, COLWILL BRUCE (CFO) acquired 5,000 shares at an average price of $1.09 for $5438.0. The insider now directly holds 11,515 shares of InMed Pharmaceuticals Inc. (INM).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.